Trex Wind-down, Inc. Stock

Equities

BPC

US8870802084

Biotechnology & Medical Research

Delayed Deutsche Boerse AG 02:23:45 2023-11-29 EST 5-day change 1st Jan Change
0.292 EUR +4.29% Intraday chart for Trex Wind-down, Inc. -.--% -.--%
6 months+4.29%

Financials

Sales 2021 887K 820K 1.22M Sales 2022 83.18K 76.96K 114K Capitalization 3.89M 3.6M 5.35M
Net income 2021 -10M -9.25M -13.74M Net income 2022 -19M -17.58M -26.1M EV / Sales 2021 9.89 x
Net cash position 2021 14.05M 13M 19.3M Net cash position 2022 8.75M 8.1M 12.02M EV / Sales 2022 -58.4 x
P/E ratio 2021
-1.34 x
P/E ratio 2022
-0.14 x
Employees 9
Yield 2021 *
-
Yield 2022
-
Free-Float 99.37%
More Fundamentals * Assessed data
Dynamic Chart
1 day+4.29%
6 months+4.29%
More quotes
1 year
0.28
Extreme 0.28
2.92
3 years
0.28
Extreme 0.28
57.50
5 years
0.28
Extreme 0.28
184.13
10 years
0.28
Extreme 0.28
184.13
More quotes
Trex Wind-Down, Inc., formerly Timber Pharmaceuticals, Inc., has filed a voluntary petition under Chapter 11 of the United States Bankruptcy Code and is winding down its business. The Company has no operation nor generates any revenue.
More about the company

Quarterly revenue - Rate of surprise